Safer Compounding in Hospitals Act of 2024

The Safer Compounding in Hospitals Act of 2024 adds a $40 Medicare payment to hospitals for each sterile intravenous drug treatment prepared using FDA-cleared automated compounding systems meeting strict safety standards. These systems must prepare medications without human handling, maintain sterile environments, verify ingredients via barcode, and ensure dose accuracy - meeting all nine FDA-defined criteria. The payment applies to Medicare discharges between October 2025 and October 2031, with an annual cap of $40 million total. Hospitals must use specific coding methods to track qualifying treatments, and the payment is designed to offset costs while maintaining current Medicare budget levels.